文献速递流行病学与生物统计医学人工智能与信息学组学、生物样本库与精准医学

预测未来SARS-CoV-2关注变异株的突变驱动因素

Predicting the mutational drivers of future SARS-CoV-2 variants of concern.
PubMed 文献 · Sci Transl Med · 2022-02-23

研究整合流行病学、进化、免疫学及基于神经网络的蛋白序列建模特征,回溯性识别SARS-CoV-2大流行不同阶段将扩散的突变,准确率高(AUROC=0.92-0.97),可提前至多四个月;模型用于预测未来扩散突变并分析其对治疗性抗体结合的影响,并在奥密克戎出现前对其组分突变给出升高的预测评分。

要点

  • ACE2介导的传播性和对群体水平宿主免疫的抵抗作为SARS-CoV-2进化主要驱动因素的权重随时间消长。
  • 模型回溯性识别将扩散突变的AUROC=0.92-0.97,可提前至多四个月。
  • 奥密克戎出现前其组分突变预测评分升高,出现期间每日预测评分快速上升。

核心结论

  • 有可能预测新出现的SARS-CoV-2关注变异株中可能出现的驱动突变。
  • 该建模方法或可应用于任何具有足够密集基因组监测数据的快速进化病原体,如流感及未知的未来大流行病毒。

研究设计与样本

  • 测试涵盖流行病学、进化、免疫学和基于神经网络的蛋白序列建模等特征的预测价值。
  • 回溯性识别SARS-CoV-2大流行不同阶段将扩散的突变,并与奥密克戎验证。

主要发现

  • ACE2介导的传播性和对群体水平宿主免疫的抵抗作为SARS-CoV-2进化主要驱动因素的权重随时间消长。
  • 回溯性识别将扩散突变的准确率高(AUROC=0.92-0.97),可提前至多四个月,跨越大流行不同阶段。
  • 模型行为与一个合理的因果结构一致,其中流行病学协变量结合了病毒适应度多样且变化的驱动因素效应。
  • 应用模型预测未来将扩散的突变并描述这些突变如何影响治疗性抗体结合。
  • 在奥密克戎验证中,其组分突变在出现前预测评分升高,出现期间每日预测评分快速上升。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SARS-CoV-2 evolution threatens vaccine- and natural infection-derived immunity as well as the efficacy of therapeutic antibodies. To improve public health preparedness, we sought to predict which existing amino acid mutations in SARS-CoV-2 might contribute to future variants of concern. We tested the predictive value of features comprising epidemiology, evolution, immunology, and neural network-based protein sequence modeling, and identified primary biological drivers of SARS-CoV-2 intra-pandemic evolution. We found evidence that ACE2-mediated transmissibility and resistance to population-level host immunity has waxed and waned as a primary driver of SARS-CoV-2 evolution over time. We retroactively identified with high accuracy (area under the receiver operator characteristic curve, AUROC=0.92-0.97) mutations that will spread, at up to four months in advance, across different phases of the pandemic. The behavior of the model was consistent with a plausible causal structure wherein epidemiological covariates combine the effects of diverse and shifting drivers of viral fitness. We applied our model to forecast mutations that will spread in the future and characterize how these mutations affect the binding of therapeutic antibodies. These findings demonstrate that it is possible to forecast the driver mutations that could appear in emerging SARS-CoV-2 variants of concern. We validate this result against Omicron, showing elevated predictive scores for its component mutations prior to emergence, and rapid score increase across daily forecasts during emergence. This modeling approach may be applied to any rapidly evolving pathogens with sufficiently dense genomic surveillance data, such as influenza, and unknown future pandemic viruses.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Maher MC, Bartha I, Weaver S, et al. Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Sci Transl Med. 2022. PMID: 35014856. doi:10.1126/scitranslmed.abk3445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。